Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 10.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 630,085 shares of the financial services provider’s stock after purchasing an additional 60,737 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich owned about 0.17% of CME Group worth $157,391,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Catalina Capital Group LLC acquired a new stake in CME Group during the 3rd quarter worth about $207,000. Radnor Capital Management LLC acquired a new stake in shares of CME Group during the third quarter worth about $209,000. Principal Financial Group Inc. boosted its position in CME Group by 4.4% in the third quarter. Principal Financial Group Inc. now owns 419,532 shares of the financial services provider’s stock valued at $92,570,000 after buying an additional 17,508 shares during the last quarter. Western Pacific Wealth Management LP increased its holdings in CME Group by 116.8% in the 3rd quarter. Western Pacific Wealth Management LP now owns 464 shares of the financial services provider’s stock worth $102,000 after buying an additional 250 shares during the period. Finally, Consolidated Planning Corp purchased a new position in CME Group during the 3rd quarter worth approximately $207,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Insider Buying and Selling at CME Group
In related news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. The trade was a 34.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 17,076 shares of company stock valued at $4,271,496 over the last quarter. 0.30% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Get Our Latest Analysis on CME
CME Group Trading Up 0.2 %
Shares of CME stock opened at $254.57 on Friday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $258.78. The company has a market cap of $91.74 billion, a price-to-earnings ratio of 26.33, a PEG ratio of 6.76 and a beta of 0.57. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a 50 day simple moving average of $240.07 and a 200-day simple moving average of $230.55.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group announced that its board has approved a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to reacquire up to 3.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
CME Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.96%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s payout ratio is 51.71%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is Myers Industries Poised for a Breakout?
- What is the MACD Indicator and How to Use it in Your Trading
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.